AU2001255380A1 - Human interferon, zinf2 - Google Patents

Human interferon, zinf2

Info

Publication number
AU2001255380A1
AU2001255380A1 AU2001255380A AU5538001A AU2001255380A1 AU 2001255380 A1 AU2001255380 A1 AU 2001255380A1 AU 2001255380 A AU2001255380 A AU 2001255380A AU 5538001 A AU5538001 A AU 5538001A AU 2001255380 A1 AU2001255380 A1 AU 2001255380A1
Authority
AU
Australia
Prior art keywords
zinf2
human interferon
interferon
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255380A
Inventor
James L. Holloway
Edward C. Thayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2001255380A1 publication Critical patent/AU2001255380A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001255380A 2000-04-14 2001-04-13 Human interferon, zinf2 Abandoned AU2001255380A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19888900P 2000-04-14 2000-04-14
US60198889 2000-04-14
PCT/US2001/012191 WO2001079289A2 (en) 2000-04-14 2001-04-13 Human interferon, zinf2

Publications (1)

Publication Number Publication Date
AU2001255380A1 true AU2001255380A1 (en) 2001-10-30

Family

ID=22735290

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255380A Abandoned AU2001255380A1 (en) 2000-04-14 2001-04-13 Human interferon, zinf2

Country Status (3)

Country Link
US (1) US20030175897A1 (en)
AU (1) AU2001255380A1 (en)
WO (1) WO2001079289A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0032134B2 (en) * 1980-01-08 1993-10-13 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
US4973479A (en) * 1982-01-15 1990-11-27 Cetus Corporation Interferon-α61
US5789551A (en) * 1993-06-11 1998-08-04 Pestka Biomedical Laboratories, Inc. Human leukocyte interferon Hu-IFN-α001
CA2323604A1 (en) * 1998-03-19 1999-09-23 Valentis, Inc. Interferon alpha plasmids and delivery systems, and methods of making and using the same

Also Published As

Publication number Publication date
US20030175897A1 (en) 2003-09-18
WO2001079289A2 (en) 2001-10-25
WO2001079289A3 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2001260327A1 (en) Chair
AU2002223028A1 (en) Inhaler
AU2002253039A1 (en) Tramadol-based medicament
AU2002317759A1 (en) Ophthalmoscope
AU2001258349A1 (en) Bisacylguanidine
AU6594401A (en) 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
AU2001240791A1 (en) Sequence
AU2002227925A1 (en) Human beta-defensin-3
AU2001252200A1 (en) Chair
AU2001267135A1 (en) Medicaments
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU2002365860A1 (en) Clothes-hanger
AU2002241065A1 (en) Heterocarpine, a human GHRH-binding protein
AU2001255380A1 (en) Human interferon, zinf2
AU2002215030A1 (en) Chair
AU2001264869A1 (en) Human secreted protein, zsig47
AU2001288231A1 (en) Human secreted protein, zzp1
AU2001266201A1 (en) Medicaments
AU2001262084A1 (en) Maurocalcine, analogues thereof and their therapeutical uses
AU1891601A (en) Novel human RNA helicase, helicain
AU2845301A (en) 4-aryl-1-difluoromethoxyimidazole
WO2002086124A8 (en) Human chemokine-13
AU2001297783A1 (en) Human chemokine-13
AU2001294812A1 (en) Human nedd-1
AU2002231726A1 (en) Human 4-nitrophenylphosphatase